Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4673)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2021 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang RN, Shen F, Pan Q, Cao HX, Chen GY, Fan JG. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease . World J Gastroenterol 2021; 27(25): 3863-3876 [PMID: 34321850 DOI: 10.3748/wjg.v27.i25.3863] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i25/3863.htm |
| Number | Citing Articles |
| 1 |
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
|
| 2 |
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, Mohammadreza Kasravi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01708-8
|
| 3 |
Shotaro Kamata, Akihiro Honda, Nonoka Kashiwagi, Ayumi Shimamura, Sayaka Yashiro, Yuna Komori, Aoi Hosoda, Noriyuki Akahoshi, Isao Ishii. Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease. Biomedicines 2024; 12(3): 624 doi: 10.3390/biomedicines12030624
|
| 4 |
Karima Abounouh, Ikram-Allah Tanouti, Ahd Ouladlahsen, Mohamed Tahiri, Wafaa Badre, Hind Dehbi, M’hammed Sarih, Soumaya Benjelloun, Pascal Pineau, Sayeh Ezzikouri. The peroxisome proliferator-activated receptor γ coactivator-1 alpha rs8192678 (Gly482Ser) variant and hepatitis B virus clearance. Infectious Diseases 2023; 55(9): 614 doi: 10.1080/23744235.2023.2228403
|
| 5 |
Jessica I. Sanchez, Edwin R. Parra, Jingjing Jiao, Luisa M. Solis Soto, Debora A. Ledesma, Omar A. Saldarriaga, Heather L. Stevenson, Laura Beretta. Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD. Cancers 2023; 15(11): 2871 doi: 10.3390/cancers15112871
|
| 6 |
Qian-Ren Zhang, Yan Dong, Jian-Gao Fan. Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2023; doi: 10.1016/j.hbpd.2023.12.007
|
| 7 |
Mohammad Shafi Kuchay, José Ignacio Martínez-Montoro, Narendra Singh Choudhary, José Carlos Fernández-García, Bruno Ramos-Molina. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines 2021; 9(10): 1346 doi: 10.3390/biomedicines9101346
|
| 8 |
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies. Medicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
|
| 9 |
Boyang Chen, Yafeng Wang, Weifeng Tang, Yu Chen, Chao Liu, Mingqiang Kang, Jinbiao Xie. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01428-0
|
| 10 |
Yanqing Li, Hu Hei, Songtao Zhang, Wenbo Gong, Yann Liu, Jianwu Qin. PGC-1α participates in tumor chemoresistance by regulating glucose metabolism and mitochondrial function. Molecular and Cellular Biochemistry 2023; 478(1): 47 doi: 10.1007/s11010-022-04477-2
|
| 11 |
Alexander A. Berezin, Zeljko Obradovic, Tetiana A. Berezina, Elke Boxhammer, Michael Lichtenauer, Alexander E. Berezin. Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines. Antioxidants 2023; 12(2): 516 doi: 10.3390/antiox12020516
|
| 12 |
Daniel Castellano-Castillo, Bruno Ramos-Molina, María Dolores Frutos, Isabel Arranz-Salas, Armando Reyes-Engel, María Isabel Queipo-Ortuño, Fernando Cardona. RNA expression changes driven by altered epigenetics status related to NASH etiology. Biomedicine & Pharmacotherapy 2024; 174: 116508 doi: 10.1016/j.biopha.2024.116508
|
| 13 |
Jorge Gutiérrez-Cuevas, Silvia Lucano-Landeros, Daniel López-Cifuentes, Arturo Santos, Juan Armendariz-Borunda. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. Cancers 2022; 15(1): 23 doi: 10.3390/cancers15010023
|
| 14 |
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
|